Serum GlycA Level Is Elevated in Active Systemic Lupus Erythematosus and Correlates to Disease Activity and Lupus Nephritis Severity

Serum GlycA Level Is Elevated in Active Systemic Lupus Erythematosus and Correlates to Disease Activity and Lupus Nephritis Severity

Objective: Reliable non-invasive biomarkers are needed to assess disease activity and prognosis in patients with systemic lupus erythematosus (SLE). Glycoprotein acetylation (GlycA), a novel biomarker for chronic inflammation, has been reported to be increased in several inflammatory diseases. We in...

Full description

Bibliographic Details
Main Authors: Tim Dierckx, Laurent Chiche, Laurent Daniel, Bernard Lauwerys, Johan Van Weyenbergh, Noémie Jourde-Chiche
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Journal of Clinical Medicine
Subjects:
systemic lupus erythematosus
disease activity
lupus nephritis severity
glycoprotein acetylation
systemic chronic inflammation
Online Access:https://www.mdpi.com/2077-0383/9/4/970

Similar Items

Similar Items